|
1
|
Chrysostomou AC, Stylianou DC,
Constantinidou A and Kostrikis LG: Cervical cancer screening
programs in Europe: The transition towards HPV vaccination and
population-based HPV testing. Viruses. 10:7292018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Siegel RL, Ward EM and Jemal A:
Global cancer incidence and mortality rates and trends-an update.
Cancer Epidemiol Biomarkers Prev. 25:16–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shrestha AD, Neupane D, Vedsted P and
Kallestrup P: Cervical cancer prevalence, incidence and mortality
in low and middle income countries: A systematic review. asian Pac
J Cancer Prev. 19:319–324. 2018.PubMed/NCBI
|
|
4
|
Radu MC, Boeru C, Pop-Tudose ME,
Necsulescu A, Dumitrescu A, Iancu CF, Nita I, Limbau AM and Zaharia
C: Human papillomavirus infection at the time of delivery. Cureus.
13:e153642021.PubMed/NCBI
|
|
5
|
Goodman A: HPV testing as a screen for
cervical cancer. BMJ. 350:h23722015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu Y, Wu L, Tong R, Yang F, Yin L, Li M,
You L, Xue J and Lu Y: PD-1/PD-L1 inhibitors in cervical cancer.
Front Pharmacol. 10:652019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang S, Wu X, Tan M, Gong J, Tan W, Bian
B, Chen M and Wang Y: Fighting fire with fire: Poisonous Chinese
herbal medicine for cancer therapy. J Ethnopharmacol. 140:33–45.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Minion LE and Tewari KS: Cervical
cancer-State of the science: From angiogenesis blockade to
checkpoint inhibition. Gynecol Oncol. 148:609–621. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Heeran AB, Berrigan HP and O'Sullivan J:
The radiation-induced bystander effect (RIBE) and its connections
with the hallmarks of cancer. Radiat Res. 192:668–679. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qin AQ, Liang ZG, Ye JX, Li J, Wang JL,
Chen CX and Song HL: Significant efficacy of additional concurrent
chemotherapy with radiotherapy for postoperative cervical cancer
with risk factors: A systematic review and meta-analysis. Asian Pac
J Cancer Prev. 17:3945–3951. 2016.PubMed/NCBI
|
|
12
|
Cao YP, Sun JY, Li MQ, Dong Y, Zhang YH,
Yan J, Huang RM and Yan X: Inhibition of G9a by a small molecule
inhibitor, UNC0642, induces apoptosis of human bladder cancer
cells. Acta Pharmacol Sin. 40:1076–1084. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu GJ, Chen JT, Tsai HC, Chen TL, Liu SH
and Chen RM: Protection of dexmedetomidine against
ischemia/reperfusion-induced apoptotic insults to neuronal cells
occurs via an intrinsic mitochondria-dependent pathway. J Cell
Biochem. 118:2635–2644. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Estaquier J, Vallette F, Vayssiere JL and
Mignotte B: The mitochondrial pathways of apoptosis. Adv Exp Med
Biol. 942:157–183. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bhola PD and Letai A: Mitochondria-judges
and executioners of cell death sentences. Mol Cell. 61:695–704.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yuan J, Li X, Zhang G, Cheng W, Wang W,
Lei Y, Ma Q and Song G: USP39 mediates p21-dependent proliferation
and neoplasia of colon cancer cells by regulating the
p53/p21/CDC2/cyclin B1 axis. Mol Carcinog. 60:265–278. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pestell RG, Albanese C, Reutens AT, Segall
JE, Lee RJ and Arnold A: The cyclins and cyclin-dependent kinase
inhibitors in hormonal regulation of proliferation and
differentiation. Endocr Rev. 20:501–534. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Strauss B, Harrison A, Coelho PA, Yata K,
Zernicka-Goetz M and Pines J: Cyclin B1 is essential for mitosis in
mouse embryos, and its nuclear export sets the time for mitosis. J
Cell Biol. 217:179–193. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jang SH, Kim AR, Park NH, Park JW and Han
IS: DRG2 regulates G2/M progression via the cyclin B1-Cdk1 complex.
Mol Cells. 39:699–704. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hong S and Laimins LA: The JAK-STAT
transcriptional regulator, STAT-5, activates the ATM DNA damage
pathway to induce HPV 31 genome amplification upon epithelial
differentiation. PLoS Pathog. 9:e10032952013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Majoros A, Platanitis E, Kernbauer-Hölzl
E, Rosebrock F, Müller M and Decker T: Canonical and non-canonical
aspects of JAK-STAT signaling: Lessons from interferons for
cytokine responses. Front Immunol. 8:292017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Welsch K, Holstein J, Laurence A and
Ghoreschi K: Targeting JAK/STAT signalling in inflammatory skin
diseases with small molecule inhibitors. Eur J Immunol.
47:1096–1107. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shan H, Yao S, Ye Y and Yu Q:
3-Deoxy-2β,16-dihydroxynagilactone E, a natural compound from
Podocarpus nagi, preferentially inhibits JAK2/STAT3 signaling by
allosterically interacting with the regulatory domain of JAK2 and
induces apoptosis of cancer cells. Acta Pharmacol Sin.
40:1578–1586. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pattison MJ, Mackenzie KF and Arthur JS:
Inhibition of JAKs in macrophages increases
lipopolysaccharide-induced cytokine production by blocking
IL-10-mediated feedback. J Immunol. 189:2784–2792. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mottok A, Renné C, Willenbrock K, Hansmann
ML and Bräuninger A: Somatic hypermutation of SOCS1 in
lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2
expression and activation of STAT6. Blood. 110:3387–3390. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
von Hoff L, Kärgel E, Franke V, McShane E,
Schulz-Beiss KW, Patone G, Schleussner N, Kolesnichenko M, Hübner
N, Daumke O, et al: Autocrine LTA signaling drives NF-κB and
JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma.
Blood. 133:1489–1494. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ghafouri-Fard S, Oskooei VK, Azari I and
Taheri M: Suppressor of cytokine signaling (SOCS) genes are
downregulated in breast cancer. World J Surg Oncol. 16:2262018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hu Y, Yu K, Wang G, Zhang D, Shi C, Ding
Y, Hong D, Zhang D, He H, Sun L, et al: Lanatoside C inhibits cell
proliferation and induces apoptosis through attenuating
Wnt/β-catenin/c-Myc signaling pathway in human gastric cancer cell.
Biochem Pharmacol. 150:280–292. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cheung YY, Chen KC, Chen H, Seng EK and
Chu JJ: Antiviral activity of lanatoside C against dengue virus
infection. Antiviral Res. 111:93–99. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nie Y, Zhang D, Jin Z, Li B, Wang X, Che
H, You Y, Qian X, Zhang Y, Zhao P and Chai G: Lanatoside C protects
mice against bleomycin-induced pulmonary fibrosis through
suppression of fibroblast proliferation and differentiation. Clin
Exp Pharmacol Physiol. 46:575–586. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Durmaz I, Guven EB, Ersahin T, Ozturk M,
Calis I and Cetin-Atalay R: Liver cancer cells are sensitive to
Lanatoside C induced cell death independent of their PTEN status.
Phytomedicine. 23:42–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kheraldine H, Gupta I, Alhussain H, Jabeen
A, Cyprian FS, Akhtar S, Al Moustafa AE and Rachid O: Substantial
cell apoptosis provoked by naked PAMAM dendrimers in HER2-positive
human breast cancer via JNK and ERK1/ERK2 signalling pathways.
Comput Struct Biotechnol J. 19:2881–2890. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mierke CT: The matrix environmental and
cell mechanical properties regulate cell migration and contribute
to the invasive phenotype of cancer cells. Rep Prog Phys.
82:0646022019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun BB, Fu LN, Wang YQ, Gao QY, Xu J, Cao
ZJ, Chen YX and Fang JY: Silencing of JMJD2B induces cell apoptosis
via mitochondria-mediated and death receptor-mediated pathway
activation in colorectal cancer. J Dig Dis. 15:491–500. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Singh A, Kukreti R, Saso L and Kukreti S:
Oxidative stress: A key modulator in neurodegenerative diseases.
Molecules. 24:15832019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Calaf GM, Ponce-Cusi R and Carrión F:
Curcumin and paclitaxel induce cell death in breast cancer cell
lines. Oncol Rep. 40:2381–2388. 2018.PubMed/NCBI
|
|
37
|
Durham GA, Williams JJL, Nasim MT and
Palmer TM: Targeting SOCS proteins to control JAK-STAT signalling
in disease. Trends Pharmacol Sci. 40:298–308. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hao Y, Chapuy B, Monti S, Sun HH, Rodig SJ
and Shipp MA: Selective JAK2 inhibition specifically decreases
Hodgkin lymphoma and mediastinal large B-cell lymphoma growth in
vitro and in vivo. Clin Cancer Res. 20:2674–2683. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li H, Wu X and Cheng X: Advances in
diagnosis and treatment of metastatic cervical cancer. J Gynecol
Oncol. 27:e432016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lim MC, Lee M, Shim SH, Nam EJ, Lee JY,
Kim HJ, Lee YY, Lee KB, Park JY, Kim YH, et al: Practice guidelines
for management of cervical cancer in Korea: A Korean society of
gynecologic oncology consensus statement. J Gynecol Oncol.
28:e222017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Oudin MJ and Weaver VM: Physical and
chemical gradients in the tumor microenvironment regulate tumor
cell invasion, migration, and metastasis. Cold Spring Harb Symp
Quant Biol. 81:189–205. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hua S, Kong X, Chen B, Zhuang W, Sun Q,
Yang W, Liu W and Zhang Y: Anticancer mechanism of lobaplatin as
monotherapy and in combination with paclitaxel in human gastric
cancer. Curr Mol Pharmacol. 11:316–325. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ling X, Bernacki RJ, Brattain MG and Li F:
Induction of survivin expression by taxol (paclitaxel) is an early
event, which is independent of taxol-mediated G2/M arrest. J Biol
Chem. 279:15196–15203. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Pan B, Liu C, Zhan X and Li J: Protegrin-1
regulates porcine granulosa cell proliferation via the
EGFR-ERK1/2/p38 signaling pathway in vitro. Front Physiol.
12:6737772021. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Striz A, DePina A, Jones R Jr, Gao X and
Yourick J: Cytotoxic, genotoxic, and toxicogenomic effects of
dihydroxyacetone in human primary keratinocytes. Cutan Ocul
Toxicol. Jul 11–2021.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Harry BL, Eckhardt SG and Jimeno A: JAK2
inhibition for the treatment of hematologic and solid malignancies.
Expert Opin Investig Drugs. 21:637–655. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Harrison C, Kiladjian JJ, Al-Ali HK,
Gisslinger H, Waltzman R, Stalbovskaya V, McQuitty M, Hunter DS,
Levy R, Knoops L, et al: JAK inhibition with ruxolitinib versus
best available therapy for myelofibrosis. N Engl J Med.
366:787–798. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Pencik J, Pham HT, Schmoellerl J, Javaheri
T, Schlederer M, Culig Z, Merkel O, Moriggl R, Grebien F and Kenner
L: JAK-STAT signaling in cancer: From cytokines to non-coding
genome. Cytokine. 87:26–36. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hedl M, Proctor DD and Abraham C: JAK2
disease-risk variants are gain of function and JAK signaling
threshold determines innate receptor-induced proinflammatory
cytokine secretion in macrophages. J Immunol. 197:3695–3704. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Quintás-Cardama A, Kantarjian H, Cortes J
and Verstovsek S: Janus kinase inhibitors for the treatment of
myeloproliferative neoplasias and beyond. Nat Rev Drug Discov.
10:127–140. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hebenstreit D, Wirnsberger G, Horejs-Hoeck
J and Duschl A: Signaling mechanisms, interaction partners, and
target genes of STAT6. Cytokine Growth Factor Rev. 17:173–188.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Bruns HA and Kaplan MH: The role of
constitutively active Stat6 in leukemia and lymphoma. Crit Rev
Oncol Hematol. 57:245–253. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhang Z, Fye S, Borecki IB and Rader JS:
Polymorphisms in immune mediators associate with risk of cervical
cancer. Gynecol Oncol. 135:69–73. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Trivedi S and Starz-Gaiano M: Drosophila
Jak/STAT signaling: Regulation and relevance in human cancer and
metastasis. Int J Mol Sci. 19:40562018. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
McGaha TL, Le M, Kodera T, Stoica C, Zhu
J, Paul WE and Bona CA: Molecular mechanisms of
interleukin-4-induced up-regulation of type I collagen gene
expression in murine fibroblasts. Arthritis Rheum. 48:2275–2284.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Cao H, Zhang J, Liu H, Wan L, Zhang H,
Huang Q, Xu E and Lai M: IL-13/STAT6 signaling plays a critical
role in the epithelial-mesenchymal transition of colorectal cancer
cells. Oncotarget. 7:61183–61198. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Reddy D, Kumavath R, Ghosh P and Barh D:
Lanatoside C induces G2/M cell cycle arrest and suppresses cancer
cell growth by attenuating MAPK, Wnt, JAK-STAT, and PI3K/AKT/mTOR
signaling pathways. Biomolecules. 9:7922019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Berman TA and Schiller JT: Human
papillomavirus in cervical cancer and oropharyngeal cancer: One
cause, two diseases. Cancer. 123:2219–2229. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Bottos A, Gotthardt D, Gill JW, Gattelli
A, Frei A, Tzankov A, Sexl V, Wodnar-Filipowicz A and Hynes NE:
Decreased NK-cell tumour immunosurveillance consequent to JAK
inhibition enhances metastasis in breast cancer models. Nat Commun.
7:122582016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Carlsson C and Johansson T: The
psychological effects of propranolol in the abstinence phase of
chronic alcoholics. Br J Psychiatry. 119:605–606. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Sánchez-Reyes K, Pedraza-Brindis EJ,
Hernández-Flores G, Bravo-Cuellar A, López-López BA, Rosas-González
VC and Ortiz-Lazareno PC: The supernatant of cervical carcinoma
cells lines induces a decrease in phosphorylation of STAT-1 and
NF-κB transcription factors associated with changes in profiles of
cytokines and growth factors in macrophages derived from U937
cells. Innate Immun. 25:344–355. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Fan J, Ren D, Wang J, Liu X, Zhang H, Wu M
and Yang G: Bruceine D induces lung cancer cell apoptosis and
autophagy via the ROS/MAPK signaling pathway in vitro and in vivo.
Cell Death Dis. 11:1262020. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Alzahrani AS: PI3K/Akt/mTOR inhibitors in
cancer: At the bench and bedside. Semin Cancer Biol. 59:125–132.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Croker BA, Kiu H and Nicholson SE: SOCS
regulation of the JAK/STAT signalling pathway. Semin Cell Dev Biol.
19:414–422. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Xiong H, Du W, Zhang YJ, Hong J, Su WY,
Tang JT, Wang YC, Lu R and Fang JY: Trichostatin A, a histone
deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing
the promoter-associated histone acetylation of SOCS1 and SOCS3 in
human colorectal cancer cells. Mol Carcinog. 51:174–184. 2012.
View Article : Google Scholar : PubMed/NCBI
|
